Brainlab said it won FDA clearance for a mobile version of its TraumaCad surgical planning software for hip replacement procedures.
The product, TraumaCad Mobile, will be marketed by Brainlab’s Voyant Health unit. The application is compatible with Mac and PC web browsers plus iOS mobile devices.
The application features automated hip-replacement planning and a digital template library. The product also supports Voyant’s KingMark calibration marker and Brainlab’s Quentry image-sharing service, the Munich-based company said.
“For over a decade, thousands of orthopedic surgeons have been using our TraumaCad technology to plan surgery. In the past several years, mobile devices have transformed how surgeons and healthcare professionals work by enhancing data access and productivity,” orthopedics general manager Marc Mackey said in a press release. “With the mobile version of TraumaCad, digital templating can now be accessed from any web browser or iPad, enabling surgeons to be more productive while also providing access to data for better inventory management.”
Munich-based Brainlab debuted the application last week at the annual meeting of the American Academy of Orthopaedic Surgeons in Las Vegas. The company acquired Tel Aviv-based Voyant in 2011.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.